Pathophysiology and treatment of IgA nephropathy in children
- PMID: 11405121
- DOI: 10.1007/s004670100582
Pathophysiology and treatment of IgA nephropathy in children
Abstract
IgA nephropathy is the most-common primary glomerulonephritis worldwide, and about 20%-50% of patients develop progressive renal failure. The pathogenesis is still unknown and treatment has not yet been established. Knowledge concerning childhood IgA nephropathy has expanded greatly in the last 10 years, and its importance as the major form of glomerulonephritis and major contributor to end-stage renal disease is also becoming apparent in children. This review focuses on the pathophysiology and treatment of IgA nephropathy in children.
Comment in
-
Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy.Pediatr Nephrol. 2002 Apr;17(4):302-4. doi: 10.1007/s00467-002-0829-y. Pediatr Nephrol. 2002. PMID: 11956889 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
